Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Australian (ASX) Biotech Industry Analysis

UpdatedDec 08, 2025
DataAggregated Company Financials
Companies33
  • 7D-1.4%
  • 3M-11.0%
  • 1Y-32.5%
  • YTD-33.2%

Over the last 7 days, the Biotech industry has dropped 1.4%, driven by a pullback from CSL of 1.2%. However, the industry is down 32% over the past year. Earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the Australian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 08 Dec 2025AU$101.8bAU$24.8bAU$4.0b19.7x25.2x4.1x
Wed, 05 Nov 2025AU$98.3bAU$25.3bAU$4.1b18.5x23.7x3.9x
Fri, 03 Oct 2025AU$112.7bAU$24.8bAU$4.1b22x27.7x4.5x
Sun, 31 Aug 2025AU$114.3bAU$25.1bAU$4.1b22.5x27.7x4.6x
Tue, 29 Jul 2025AU$145.0bAU$24.4bAU$3.8b49.2x37.7x5.9x
Thu, 26 Jun 2025AU$129.0bAU$24.5bAU$3.9b20.1x33.3x5.3x
Sat, 24 May 2025AU$133.4bAU$24.6bAU$3.9b20.9x34.3x5.4x
Mon, 21 Apr 2025AU$129.6bAU$24.9bAU$3.9b20.4x32.9x5.2x
Wed, 19 Mar 2025AU$134.7bAU$25.0bAU$4.0b21.4x34.1x5.4x
Fri, 14 Feb 2025AU$139.5bAU$25.2bAU$3.8b22.7x36.3x5.5x
Sun, 12 Jan 2025AU$153.0bAU$25.0bAU$3.7b24.1x40.8x6.1x
Tue, 10 Dec 2024AU$150.1bAU$23.9bAU$3.6b25.3x42.2x6.3x
Thu, 07 Nov 2024AU$151.2bAU$23.5bAU$3.5b26.8x43.3x6.4x
Sat, 05 Oct 2024AU$152.1bAU$22.5bAU$3.3b28x45.7x6.8x
Mon, 02 Sep 2024AU$159.3bAU$22.8bAU$3.5b30x45.3x7x
Wed, 31 Jul 2024AU$160.6bAU$22.5bAU$3.3b31.9x48.5x7.1x
Fri, 28 Jun 2024AU$153.5bAU$22.1bAU$3.2b31.9x47.3x6.9x
Sun, 26 May 2024AU$145.8bAU$22.2bAU$3.2b31.1x45x6.6x
Tue, 23 Apr 2024AU$138.9bAU$22.9bAU$3.4b28.9x41.3x6.1x
Thu, 21 Mar 2024AU$142.6bAU$22.5bAU$3.3b29.1x43.2x6.3x
Sat, 17 Feb 2024AU$144.5bAU$22.3bAU$3.3b31x44x6.5x
Mon, 15 Jan 2024AU$147.8bAU$20.5bAU$2.7b34.6x54.4x7.2x
Wed, 13 Dec 2023AU$137.1bAU$20.8bAU$2.8b33.5x49.6x6.6x
Fri, 10 Nov 2023AU$128.7bAU$21.4bAU$2.9b30.8x44.9x6x
Sun, 08 Oct 2023AU$128.1bAU$21.5bAU$2.8b29.7x45.4x6x
Tue, 05 Sep 2023AU$137.1bAU$21.3bAU$2.8b33.7x49.3x6.5x
Thu, 03 Aug 2023AU$138.3bAU$18.3bAU$2.4b36.6x58.5x7.6x
Sat, 01 Jul 2023AU$142.7bAU$18.2bAU$2.4b37.7x60.7x7.9x
Mon, 29 May 2023AU$155.7bAU$18.4bAU$2.4b39.9x65x8.5x
Wed, 26 Apr 2023AU$155.7bAU$18.1bAU$2.3b42x66.4x8.6x
Fri, 24 Mar 2023AU$146.8bAU$17.9bAU$2.3b39.6x63.6x8.2x
Sun, 19 Feb 2023AU$151.9bAU$17.3bAU$2.3b51.3x66.5x8.8x
Tue, 17 Jan 2023AU$146.7bAU$15.5bAU$2.4b50.9x60x9.5x
Thu, 15 Dec 2022AU$152.8bAU$15.7bAU$2.5b47.4x61.3x9.7x
Price to Earnings Ratio

61.3x


Total Market Cap: AU$152.8bTotal Earnings: AU$2.5bTotal Revenue: AU$15.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Australian Biotech Industry Price to Earnings3Y Average 46x202320242025
Current Industry PE
  • Investors are pessimistic on the Australian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 25.2x which is lower than its 3-year average PE of 46.0x.
  • The 3-year average PS ratio of 6.6x is higher than the industry's current PS ratio of 4.1x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 18% per year over the last three years.
  • Revenues for these companies have grown 16% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Australian Healthcare industry?

AU Market0.058%
Healthcare-2.24%
Biotech-1.37%
Biotech-1.37%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CSL CSLAU$185.501.0%
+AU$897.9m		-34.1%PE19.8x
MSB MesoblastAU$2.732.2%
+AU$77.0m		65.0%PS135.2x
CUV Clinuvel PharmaceuticalsAU$12.706.9%
+AU$41.2m		2.3%PE17.6x
DXB DimerixAU$0.5612.0%
+AU$36.0m		55.6%PS60.2x
PYC PYC TherapeuticsAU$1.513.1%
+AU$26.2m		-0.3%PS37.5x

Latest News

ATX
AU$0.12
Amplia Therapeutics
7D
-9.3%
1Y
42.4%
CSL
AU$185.50
CSL
7D
1.0%
1Y
-34.1%

CSL: Shares Will Recover As Seqirus Headwinds Ease After Recent Pullback

Analysts have trimmed their price target on CSL slightly, from about A$230 to A$225, reflecting tempered expectations for Seqirus amid weaker U.S. vaccination trends and the indefinite deferral of the planned vaccine business demerger, even as they note that the recent share price correction has opened a more attractive entry point. Analyst Commentary Analyst views on CSL have turned more constructive following the share price pullback, even as earnings expectations have been nudged lower to reflect the softer outlook for Seqirus.
IMM
AU$0.26
Immutep
7D
-13.6%
1Y
-23.9%
RAD
AU$0.021
Radiopharm Theranostics
7D
-8.7%
1Y
-48.8%
RAC
AU$2.67
Race Oncology
7D
-5.3%
1Y
90.7%
PYC
AU$1.51
PYC Therapeutics
7D
3.1%
1Y
-0.3%
MSB
AU$2.73
Mesoblast
7D
2.2%
1Y
65.0%
CYP
AU$0.27
Cynata Therapeutics
7D
8.2%
1Y
23.3%
OCC
AU$1.05
Orthocell
7D
2.5%
1Y
10.6%
TLX
AU$14.59
Telix Pharmaceuticals
7D
-3.1%
1Y
-41.2%
PAR
AU$0.34
Paradigm Biopharmaceuticals
7D
-10.5%
1Y
-36.4%

Weekly Picks: 💻 A Hedge Against US Government Shutdown And 2 More Picks

Oct 21
Weekly Picks: 💻 A Hedge Against US Government Shutdown And 2 More Picks
TTX
AU$3.80
Tetratherix
7D
-7.5%
1Y
n/a
CUV
AU$12.70
Clinuvel Pharmaceuticals
7D
6.9%
1Y
2.3%
ACW
AU$0.053
Actinogen Medical
7D
-10.2%
1Y
71.0%
DXB
AU$0.56
Dimerix
7D
12.0%
1Y
55.6%
1AI
AU$0.016
Algorae Pharmaceuticals
7D
14.3%
1Y
100.0%